Stock News & Analysis

AstraZeneca Stock Is Up 10% on Tariff News. But Is the Pharmaceutical Giant a Buy?
Editors’ Picks
Recent Articles

Sep 29, 2025
by James McClenathen
The Best Balance Transfer Cards This Week, Sept. 29, 2025: Up to 2 Full Years of Interest-Free Breathing Room
Pay down debt interest-free with this week's leading balance transfer cards -- get up to two years of 0% intro APR plus no annual fees when you compare top offers.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.